Zhonglin Qu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhonglin Qu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Robin Catchpoole
Biomedical Research, Children's Cancer Research Unit, Kids Research, Sydney Children's Hospital Network, Westmead, NSW, Australia
9 shared publications - Quang Vinh Nguyen
School of Computer, Data and Mathematical Sciences, Western Sydney University, Parramatta, NSW, Australia
9 shared publications - Paul J. Kennedy
University of Technology Sydney
7 shared publications - Simeon Simoff
Western Sydney University
6 shared publications - Chng Wei Lau
Western Sydney University
4 shared publications Chng Wei Lau
3 shared publications
Latest Publications
- Open Access
- 16 September 2025
- Published by Association for Computing Machinery (ACM)
- p. 1-7
Using Machine Learning Explainer SHAP to Improve Genomic Data Heatmap Visualisation on a Dashboard
Finding insights in large and complex high-dimensional numerical genomic data with many numerical values of the gene expression or protein marker is challenging. Machine learning (ML) explainer SHapley Additive exPlanations (SHAP) is an explainable artificial intelligence (XAI) approach which provides insights into how each feature influences the model's predictions and enhances transparency and trust in ML models. Visualisations are typically used to support XAI, but there is limited research that utilises XAI to enhance visualisation outcomes. This paper presents a novel method that utilises an interactive visualisation dashboard, incorporating explainer SHAP, to select more relevant genomic features and enhance the visual analytics dashboard outcomes. This is crucial for genomic data analytics due to the high number of numerical gene features, which is not effective in analysing and visualising with the limited space and human cognitive load. We demonstrate the effectiveness of our new method on two case studies with Rhabdomyosarcoma (RMS) datasets and Acute Lymphoblastic Leukaemia (ALL) with over 200 selected gene features. The ML explainer SHAP method ranks and finds essential features from a high-dimensional numerical genomic dataset, and the ranked results are applied to the heatmap on the interactive visualisation dashboard to reduce cognitive clutter.
- 16 September 2025
- Published by Association for Computing Machinery (ACM)
- p. 1-7
Open AccessUsing Machine Learning Explainer SHAP to Improve Genomic Data Heatmap Visualisation on a Dashboard
Finding insights in large and complex high-dimensional numerical genomic data with many numerical values of the gene expression or protein marker is challenging. Machine learning (ML) explainer SHapley Additive exPlanations (SHAP) is an explainable artificial intelligence (XAI) approach which provides insights into how each feature influences the model's predictions and enhances transparency and trust in ML models. Visualisations are typically used to support XAI, but there is limited research that utilises XAI to enhance visualisation outcomes. This paper presents a novel method that utilises an interactive visualisation dashboard, incorporating explainer SHAP, to select more relevant genomic features and enhance the visual analytics dashboard outcomes. This is crucial for genomic data analytics due to the high number of numerical gene features, which is not effective in analysing and visualising with the limited space and human cognitive load. We demonstrate the effectiveness of our new method on two case studies with Rhabdomyosarcoma (RMS) datasets and Acute Lymphoblastic Leukaemia (ALL) with over 200 selected gene features. The ML explainer SHAP method ranks and finds essential features from a high-dimensional numerical genomic dataset, and the ranked results are applied to the heatmap on the interactive visualisation dashboard to reduce cognitive clutter.
- Open Access
- 9 April 2025
- Published by MDPI AG in Journal of Sensor and Actuator Networks
- Vol. 14 (2) , 41
Lossless Compression with Trie-Based Shared Dictionary for Omics Data in Edge–Cloud Frameworks
The growing complexity and volume of genomic and omics data present critical challenges for storage, transfer, and analysis in edge–cloud platforms. Existing compression techniques often involve trade-offs between efficiency and speed, requiring innovative approaches that ensure scalability and cost-effectiveness. This paper introduces a lossless compression method that integrates Trie-based shared dictionaries within an edge–cloud architecture. It presents a software-centric scientific research process of the design and evaluation of the proposed compression method. By enabling localized preprocessing at the edge, our approach reduces data redundancy before cloud transmission, thereby optimizing both storage and network efficiency. A global shared dictionary is constructed using N-gram analysis to identify and prioritize repeated sequences across multiple files. A lightweight index derived from this dictionary is then pushed to edge nodes, where Trie-based sequence replacement is applied to eliminate redundancy locally. The preprocessed data are subsequently transmitted to the cloud, where advanced compression algorithms, such as Zstd, GZIP, Snappy, and LZ4, further compress them. Evaluation on real patient omics datasets from B-cell Acute Lymphoblastic Leukemia (B-ALL) and Chronic Lymphocytic Leukemia (CLL) demonstrates that edge preprocessing significantly improves compression ratios, reduces upload times, and enhances scalability in hybrid cloud frameworks.
- 9 April 2025
- Published by MDPI AG in Journal of Sensor and Actuator Networks
- Vol. 14 (2) , 41
Open AccessLossless Compression with Trie-Based Shared Dictionary for Omics Data in Edge–Cloud Frameworks
The growing complexity and volume of genomic and omics data present critical challenges for storage, transfer, and analysis in edge–cloud platforms. Existing compression techniques often involve trade-offs between efficiency and speed, requiring innovative approaches that ensure scalability and cost-effectiveness. This paper introduces a lossless compression method that integrates Trie-based shared dictionaries within an edge–cloud architecture. It presents a software-centric scientific research process of the design and evaluation of the proposed compression method. By enabling localized preprocessing at the edge, our approach reduces data redundancy before cloud transmission, thereby optimizing both storage and network efficiency. A global shared dictionary is constructed using N-gram analysis to identify and prioritize repeated sequences across multiple files. A lightweight index derived from this dictionary is then pushed to edge nodes, where Trie-based sequence replacement is applied to eliminate redundancy locally. The preprocessed data are subsequently transmitted to the cloud, where advanced compression algorithms, such as Zstd, GZIP, Snappy, and LZ4, further compress them. Evaluation on real patient omics datasets from B-cell Acute Lymphoblastic Leukemia (B-ALL) and Chronic Lymphocytic Leukemia (CLL) demonstrates that edge preprocessing significantly improves compression ratios, reduces upload times, and enhances scalability in hybrid cloud frameworks.
- Open Access
- 23 December 2023
- Published by MDPI AG in Journal of Imaging
- Vol. 10 (1) , 3
Exocentric and Egocentric Views for Biomedical Data Analytics in Virtual Environments—A Usability Study
Biomedical datasets are usually large and complex, containing biological information about a disease. Computational analytics and the interactive visualisation of such data are essential decision-making tools for disease diagnosis and treatment. Oncology data models were observed in a virtual reality environment to analyse gene expression and clinical data from a cohort of cancer patients. The technology enables a new way to view information from the outside in (exocentric view) and the inside out (egocentric view), which is otherwise not possible on ordinary displays. This paper presents a usability study on the exocentric and egocentric views of biomedical data visualisation in virtual reality and their impact on usability on human behaviour and perception. Our study revealed that the performance time was faster in the exocentric view than in the egocentric view. The exocentric view also received higher ease-of-use scores than the egocentric view. However, the influence of usability on time performance was only evident in the egocentric view. The findings of this study could be used to guide future development and refinement of visualisation tools in virtual reality.
- 23 December 2023
- Published by MDPI AG in Journal of Imaging
- Vol. 10 (1) , 3
Open AccessExocentric and Egocentric Views for Biomedical Data Analytics in Virtual Environments—A Usability Study
Biomedical datasets are usually large and complex, containing biological information about a disease. Computational analytics and the interactive visualisation of such data are essential decision-making tools for disease diagnosis and treatment. Oncology data models were observed in a virtual reality environment to analyse gene expression and clinical data from a cohort of cancer patients. The technology enables a new way to view information from the outside in (exocentric view) and the inside out (egocentric view), which is otherwise not possible on ordinary displays. This paper presents a usability study on the exocentric and egocentric views of biomedical data visualisation in virtual reality and their impact on usability on human behaviour and perception. Our study revealed that the performance time was faster in the exocentric view than in the egocentric view. The exocentric view also received higher ease-of-use scores than the egocentric view. However, the influence of usability on time performance was only evident in the egocentric view. The findings of this study could be used to guide future development and refinement of visualisation tools in virtual reality.
- Open Access
- 20 December 2023
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 23 (1) , 1-15
Understanding cancer patient cohorts in virtual reality environment for better clinical decisions: a usability study
Background: Visualising patient genomic data in a cohort with embedding data analytics models can provide relevant and sensible patient comparisons to assist a clinician with treatment decisions. As immersive technology is actively used around the medical world, there is a rising demand for an efficient environment that can effectively display genomic data visualisations on immersive devices such as a Virtual Reality (VR) environment. The VR technology will allow clinicians, biologists, and computer scientists to explore a cohort of individual patients within the 3D environment. However, demonstrating the feasibility of the VR prototype needs domain users’ feedback for future user-centred design and a better cognitive model of human–computer interactions. There is limited research work for collecting and integrating domain knowledge into the prototype design. Objective: A usability study for the VR prototype–-Virtual Reality to Observe Oncology data Models (VROOM) was implemented. VROOM was designed based on a preliminary study among medical users. The goals of this usability study included establishing a baseline of user experience, validating user performance measures, and identifying potential design improvements that are to be addressed to improve efficiency, functionality, and end-user satisfaction. Methods: The study was conducted with a group of domain users (10 males, 10 females) with portable VR devices and camera equipment. These domain users included medical users such as clinicians and genetic scientists and computing domain users such as bioinformatics and data analysts. Users were asked to complete routine tasks based on a clinical scenario. Sessions were recorded and analysed to identify potential areas for improvement to the data visual analytics projects in the VR environment. The one-hour usability study included learning VR interaction gestures, running visual analytics tool, and collecting before and after feedback. The feedback was analysed with different methods to measure effectiveness. The statistical method Mann–Whitney U test was used to analyse various task performances among the different participant groups, and multiple data visualisations were created to find insights from questionnaire answers. Results: The usability study investigated the feasibility of using VR for genomic data analysis in domain users’ daily work. From the feedback, 65% of the participants, especially clinicians (75% of them), indicated that the VR prototype is potentially helpful for domain users’ daily work but needed more flexibility, such as allowing them to define their features for machine learning part, adding new patient data, and importing their datasets in a better way. We calculated the engaged time for each task and compared them among different user groups. Computing domain users spent 50% more time exploring the algorithms and datasets than medical domain users. Additionally, the medical domain users engaged in the data visual analytics parts (approximately 20%) longer than the computing domain users.
- 20 December 2023
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 23 (1) , 1-15
Open AccessUnderstanding cancer patient cohorts in virtual reality environment for better clinical decisions: a usability study
Background: Visualising patient genomic data in a cohort with embedding data analytics models can provide relevant and sensible patient comparisons to assist a clinician with treatment decisions. As immersive technology is actively used around the medical world, there is a rising demand for an efficient environment that can effectively display genomic data visualisations on immersive devices such as a Virtual Reality (VR) environment. The VR technology will allow clinicians, biologists, and computer scientists to explore a cohort of individual patients within the 3D environment. However, demonstrating the feasibility of the VR prototype needs domain users’ feedback for future user-centred design and a better cognitive model of human–computer interactions. There is limited research work for collecting and integrating domain knowledge into the prototype design. Objective: A usability study for the VR prototype–-Virtual Reality to Observe Oncology data Models (VROOM) was implemented. VROOM was designed based on a preliminary study among medical users. The goals of this usability study included establishing a baseline of user experience, validating user performance measures, and identifying potential design improvements that are to be addressed to improve efficiency, functionality, and end-user satisfaction. Methods: The study was conducted with a group of domain users (10 males, 10 females) with portable VR devices and camera equipment. These domain users included medical users such as clinicians and genetic scientists and computing domain users such as bioinformatics and data analysts. Users were asked to complete routine tasks based on a clinical scenario. Sessions were recorded and analysed to identify potential areas for improvement to the data visual analytics projects in the VR environment. The one-hour usability study included learning VR interaction gestures, running visual analytics tool, and collecting before and after feedback. The feedback was analysed with different methods to measure effectiveness. The statistical method Mann–Whitney U test was used to analyse various task performances among the different participant groups, and multiple data visualisations were created to find insights from questionnaire answers. Results: The usability study investigated the feasibility of using VR for genomic data analysis in domain users’ daily work. From the feedback, 65% of the participants, especially clinicians (75% of them), indicated that the VR prototype is potentially helpful for domain users’ daily work but needed more flexibility, such as allowing them to define their features for machine learning part, adding new patient data, and importing their datasets in a better way. We calculated the engaged time for each task and compared them among different user groups. Computing domain users spent 50% more time exploring the algorithms and datasets than medical domain users. Additionally, the medical domain users engaged in the data visual analytics parts (approximately 20%) longer than the computing domain users.
- 5 October 2023
- Published by Taylor & Francis
- p. 174-196
Biomedical Data Analytics and Visualisation—A Methodological Framework
Biomedical data analytics have become a major decision-making aid for the diagnosis and treatment of diseases. Computational and visual analytics enable effective exploration and making sense of large and complex data through the deployment of appropriate machine learning and statistical analytics methods, meaningful visualisation, and human–information interaction. This chapter serves as a tutorial that provides guidelines, discussion, and reviews on methods and technologies that have been used for biomedical data analytics. We discuss the major processes of biomedical data analytics that are required to produce effective analytical outcomes. The chapter covers comprehensive discussions on computational analytics strategies, including feature selection, feature extraction, and clustering. Methods and several aspects of visual analytics and interactive visualisation in biomedical data analytics are also thoroughly explained and illustrated, including scatter plots, heat maps, parallel coordinates, network and graph visualisations, tailored visualisation, and visualisation in emerging technologies (such as virtual reality and augmented reality), as well as the human aspect of visualisation.
- 5 October 2023
- Published by Taylor & Francis
- p. 174-196
Biomedical Data Analytics and Visualisation—A Methodological Framework
Biomedical data analytics have become a major decision-making aid for the diagnosis and treatment of diseases. Computational and visual analytics enable effective exploration and making sense of large and complex data through the deployment of appropriate machine learning and statistical analytics methods, meaningful visualisation, and human–information interaction. This chapter serves as a tutorial that provides guidelines, discussion, and reviews on methods and technologies that have been used for biomedical data analytics. We discuss the major processes of biomedical data analytics that are required to produce effective analytical outcomes. The chapter covers comprehensive discussions on computational analytics strategies, including feature selection, feature extraction, and clustering. Methods and several aspects of visual analytics and interactive visualisation in biomedical data analytics are also thoroughly explained and illustrated, including scatter plots, heat maps, parallel coordinates, network and graph visualisations, tailored visualisation, and visualisation in emerging technologies (such as virtual reality and augmented reality), as well as the human aspect of visualisation.
- 5 October 2023
- Published by Taylor & Francis
- p. 197-214
Visualisation for Explainable Machine Learning in Biomedical Data Analysis
This chapter covers innovations in biomedical data mining and interpretations, especially using visualisations in interpretable machine learning for biomedical data analysis. Visualisations are important in presenting artificial intelligence models and validating the machine learning results. There are more new and complex machine learning methods that have been created to assist decision-making in recent years in the medical domain. Most of them are treated as “black boxes”, as the training and prediction processes are hidden in complicated mathematical theories. Visualisation is a way to reveal the process and help a human understand the cause of a decision. Knowing the “why” for the prediction results and “how” the model works can improve users’ trust in artificial intelligence results. The chapter introduces different visualisations used in interpreting supervised and unsupervised machine learning models for biomedical data. We also provide discussions and future work on using visualisations in interpreting data mining results in the medical domain.
- 5 October 2023
- Published by Taylor & Francis
- p. 197-214
Visualisation for Explainable Machine Learning in Biomedical Data Analysis
This chapter covers innovations in biomedical data mining and interpretations, especially using visualisations in interpretable machine learning for biomedical data analysis. Visualisations are important in presenting artificial intelligence models and validating the machine learning results. There are more new and complex machine learning methods that have been created to assist decision-making in recent years in the medical domain. Most of them are treated as “black boxes”, as the training and prediction processes are hidden in complicated mathematical theories. Visualisation is a way to reveal the process and help a human understand the cause of a decision. Knowing the “why” for the prediction results and “how” the model works can improve users’ trust in artificial intelligence results. The chapter introduces different visualisations used in interpreting supervised and unsupervised machine learning models for biomedical data. We also provide discussions and future work on using visualisations in interpreting data mining results in the medical domain.
- Open Access
- 10 February 2023
- Published by Springer Nature in Research Square
Understanding Cancer Patient Cohorts in Virtual Reality Environment for Better Clinical Decisions: A Usability Study
Background Visualising patient genomic data in a cohort with embedding data analytics models can provide relevant and sensible patient comparisons to assist a clinician with treatment decisions. As immersive technology is actively used around the medical world, there is a rising demand for an efficient environment that can effectively display genomic data visualisations on immersive devices such as a Virtual Reality (VR) environment. The VR technology will allow clinicians, biologists, and computer scientists to explore a cohort of individual patients within the 3D environment. However, demonstrating the feasibility of the VR prototype needs domain users’ feedback for future user-centric design and a better cognitive model of human-computer interactions. There is limited research work for collecting and integrating domain knowledge into the prototype design. Objective A usability study for the VR prototype—Virtual Reality to Observe Oncology data Models (VROOM) was implemented. VROOM was designed based on a preliminary study among medical users. The goals of this usability study included establishing a baseline of user experience, validating user performance measures, and identifying potential design improvements that are to be addressed to improve efficiency, functionality, and end-user satisfaction. Methods The study was conducted with a group of domain users (10 males, 10 females) with portable VR devices and camera equipment. These domain users included medical users such as clinicians and genetic scientists and computing domain users such as bioinformatics and data analysts. Users were asked to complete routine tasks based on a clinical scenario. Sessions were recorded and analysed to identify potential areas for improvement to the data visual analytics projects in the VR environment. The one-hour usability study included learning VR interaction gestures, running visual analytics tool, and collecting before and after feedback. The feedback was analysed with different methods to measure effectiveness. The statistical method Mann-Whitney U test was used to analyse various task performances among the different participant groups, and multiple data visualisations were created to find insights from questionnaire answers. Results The usability study investigated the feasibility of using VR for genomic data analysis in domain users’ daily work. From the feedback, 65% of the participants, especially clinicians (75% of them), indicated that the VR prototype is potentially helpful for domain users’ daily work but needed more flexibility, such as allowing them to define their features for machine learning part, adding new patient data, and importing their datasets in a better way. We calculated the engaged time for each task and compared them among different user groups. Computing domain users spent 50% more time exploring the algorithms and datasets than the medical domain users. Additionally, the medical domain users engaged in the data visual analytics parts (approximately 20%) longer than the computing domain users.
- 10 February 2023
- Published by Springer Nature in Research Square
Open AccessUnderstanding Cancer Patient Cohorts in Virtual Reality Environment for Better Clinical Decisions: A Usability Study
Background Visualising patient genomic data in a cohort with embedding data analytics models can provide relevant and sensible patient comparisons to assist a clinician with treatment decisions. As immersive technology is actively used around the medical world, there is a rising demand for an efficient environment that can effectively display genomic data visualisations on immersive devices such as a Virtual Reality (VR) environment. The VR technology will allow clinicians, biologists, and computer scientists to explore a cohort of individual patients within the 3D environment. However, demonstrating the feasibility of the VR prototype needs domain users’ feedback for future user-centric design and a better cognitive model of human-computer interactions. There is limited research work for collecting and integrating domain knowledge into the prototype design. Objective A usability study for the VR prototype—Virtual Reality to Observe Oncology data Models (VROOM) was implemented. VROOM was designed based on a preliminary study among medical users. The goals of this usability study included establishing a baseline of user experience, validating user performance measures, and identifying potential design improvements that are to be addressed to improve efficiency, functionality, and end-user satisfaction. Methods The study was conducted with a group of domain users (10 males, 10 females) with portable VR devices and camera equipment. These domain users included medical users such as clinicians and genetic scientists and computing domain users such as bioinformatics and data analysts. Users were asked to complete routine tasks based on a clinical scenario. Sessions were recorded and analysed to identify potential areas for improvement to the data visual analytics projects in the VR environment. The one-hour usability study included learning VR interaction gestures, running visual analytics tool, and collecting before and after feedback. The feedback was analysed with different methods to measure effectiveness. The statistical method Mann-Whitney U test was used to analyse various task performances among the different participant groups, and multiple data visualisations were created to find insights from questionnaire answers. Results The usability study investigated the feasibility of using VR for genomic data analysis in domain users’ daily work. From the feedback, 65% of the participants, especially clinicians (75% of them), indicated that the VR prototype is potentially helpful for domain users’ daily work but needed more flexibility, such as allowing them to define their features for machine learning part, adding new patient data, and importing their datasets in a better way. We calculated the engaged time for each task and compared them among different user groups. Computing domain users spent 50% more time exploring the algorithms and datasets than the medical domain users. Additionally, the medical domain users engaged in the data visual analytics parts (approximately 20%) longer than the computing domain users.
- 5 December 2022
- Published by Springer Nature
- p. 58-72
Enhancing Understandability of Omics Data with SHAP, Embedding Projections and Interactive Visualisations
- 5 December 2022
- Published by Springer Nature
- p. 58-72
Enhancing Understandability of Omics Data with SHAP, Embedding Projections and Interactive Visualisations
- Open Access
- 5 July 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-18
Virtual reality for the observation of oncology models (VROOM): immersive analytics for oncology patient cohorts
The significant advancement of inexpensive and portable virtual reality (VR) and augmented reality devices has re-energised the research in the immersive analytics field. The immersive environment is different from a traditional 2D display used to analyse 3D data as it provides a unified environment that supports immersion in a 3D scene, gestural interaction, haptic feedback and spatial audio. Genomic data analysis has been used in oncology to understand better the relationship between genetic profile, cancer type, and treatment option. This paper proposes a novel immersive analytics tool for cancer patient cohorts in a virtual reality environment, virtual reality to observe oncology data models. We utilise immersive technologies to analyse the gene expression and clinical data of a cohort of cancer patients. Various machine learning algorithms and visualisation methods have also been deployed in VR to enhance the data interrogation process. This is supported with established 2D visual analytics and graphical methods in bioinformatics, such as scatter plots, descriptive statistical information, linear regression, box plot and heatmap into our visualisation. Our approach allows the clinician to interrogate the information that is familiar and meaningful to them while providing them immersive analytics capabilities to make new discoveries toward personalised medicine.
- 5 July 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-18
Open AccessVirtual reality for the observation of oncology models (VROOM): immersive analytics for oncology patient cohorts
The significant advancement of inexpensive and portable virtual reality (VR) and augmented reality devices has re-energised the research in the immersive analytics field. The immersive environment is different from a traditional 2D display used to analyse 3D data as it provides a unified environment that supports immersion in a 3D scene, gestural interaction, haptic feedback and spatial audio. Genomic data analysis has been used in oncology to understand better the relationship between genetic profile, cancer type, and treatment option. This paper proposes a novel immersive analytics tool for cancer patient cohorts in a virtual reality environment, virtual reality to observe oncology data models. We utilise immersive technologies to analyse the gene expression and clinical data of a cohort of cancer patients. Various machine learning algorithms and visualisation methods have also been deployed in VR to enhance the data interrogation process. This is supported with established 2D visual analytics and graphical methods in bioinformatics, such as scatter plots, descriptive statistical information, linear regression, box plot and heatmap into our visualisation. Our approach allows the clinician to interrogate the information that is familiar and meaningful to them while providing them immersive analytics capabilities to make new discoveries toward personalised medicine.
- Open Access
- 1 January 2022
- Published by Innovative Healthcare Institute in Innovations in Digital Health, Diagnostics, and Biomarkers
- Vol. 2 (2022) , 27-39
Review of Innovative Immersive Technologies for Healthcare Applications
Immersive technologies, including virtual reality (VR), augmented reality (AR), and mixed reality (MR), can connect people using enhanced data visualizations to better involve stakeholders as integral members of the process. Immersive technologies have started to change the research on multidimensional genomic data analysis for disease diagnostics and treatments. Immersive technologies are highlighted in some research for health and clinical needs, especially for precision medicine innovation. The use of immersive technology for genomic data analysis has recently received attention from the research community. Genomic data analytics research seeks to integrate immersive technologies to build more natural human-computer interactions that allow better perception engagements. Immersive technologies, especially VR, help humans perceive the digital world as real and give learning output with lower performance errors and higher accuracy. However, there are limited reviews about immersive technologies used in healthcare and genomic data analysis with specific digital health applications. This paper contributes a comprehensive review of using immersive technologies for digital health applications, including patient-centric applications, medical domain education, and data analysis, especially genomic data visual analytics. We highlight the evolution of a visual analysis using VR as a case study for how immersive technologies step, can by step, move into the genomic data analysis domain. The discussion and conclusion summarize the current immersive technology applications' usability, innovation, and future work in the healthcare domain, and digital health data visual analytics.
- 1 January 2022
- Published by Innovative Healthcare Institute in Innovations in Digital Health, Diagnostics, and Biomarkers
- Vol. 2 (2022) , 27-39
Open AccessReview of Innovative Immersive Technologies for Healthcare Applications
Immersive technologies, including virtual reality (VR), augmented reality (AR), and mixed reality (MR), can connect people using enhanced data visualizations to better involve stakeholders as integral members of the process. Immersive technologies have started to change the research on multidimensional genomic data analysis for disease diagnostics and treatments. Immersive technologies are highlighted in some research for health and clinical needs, especially for precision medicine innovation. The use of immersive technology for genomic data analysis has recently received attention from the research community. Genomic data analytics research seeks to integrate immersive technologies to build more natural human-computer interactions that allow better perception engagements. Immersive technologies, especially VR, help humans perceive the digital world as real and give learning output with lower performance errors and higher accuracy. However, there are limited reviews about immersive technologies used in healthcare and genomic data analysis with specific digital health applications. This paper contributes a comprehensive review of using immersive technologies for digital health applications, including patient-centric applications, medical domain education, and data analysis, especially genomic data visual analytics. We highlight the evolution of a visual analysis using VR as a case study for how immersive technologies step, can by step, move into the genomic data analysis domain. The discussion and conclusion summarize the current immersive technology applications' usability, innovation, and future work in the healthcare domain, and digital health data visual analytics.